Summary & Overview
HCPCS L8612: Aqueous Shunt, Implantable Ophthalmic Device
HCPCS Level II code L8612 designates an aqueous shunt, an implantable ophthalmic device used to divert aqueous humor and manage intraocular pressure in glaucoma care. This device-level code is significant for hospitals, ambulatory surgical centers, and ophthalmology practices because it affects device billing, coverage determinations, and device-specific supply reporting across payers nationally.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of how the code is used in surgical and device supply lines, typical sites of service, and payer coverage considerations. The publication outlines available benchmarks for utilization and reimbursement where available, recent policy updates that affect device coding and coverage, and the clinical context for use of aqueous shunts in glaucoma management.
The report provides practical reference material for billing and revenue cycle teams, compliance officers, and clinical leaders seeking clarity on device classification, payer coverage patterns, and documentation points relevant to implantable ophthalmic devices. Data not provided in the input are noted as unavailable.
Billing Code Overview
HCPCS Level II code L8612 represents an aqueous shunt device used to divert aqueous humor for the treatment of glaucoma and related intraocular pressure conditions. The service type for this code is implantable ophthalmic device, and the typical site of service is an operating room or ambulatory surgical center where ophthalmic surgical implants are placed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a middle-aged or elderly individual with refractory glaucoma in whom medical therapy and laser trabeculoplasty have failed to control intraocular pressure. The ophthalmologist evaluates the patient in an outpatient ophthalmology clinic, documents progressive optic nerve damage, visual field loss, and elevated intraocular pressure despite maximal tolerated topical medications. Preoperative workup includes history, visual acuity, slit-lamp exam, gonioscopy, pachymetry, and informed consent. The procedure, L8612 (aqueous shunt), is generally performed in an ambulatory surgery center or hospital outpatient department under monitored anesthesia care or general anesthesia. The surgeon places a glaucoma drainage device (aqueous shunt) to divert aqueous humor from the anterior chamber to a subconjunctival reservoir to lower intraocular pressure. Typical perioperative workflow includes preoperative marking, sterile prepping, conjunctival dissection, device placement with tube insertion into the anterior chamber, patch graft or scleral tunnel coverage as indicated, conjunctival closure, and postoperative topical antibiotics and steroids. Postoperative visits at day 1, week 1, and month 1 (and ongoing) document intraocular pressure, tube position, corneal clarity, and any complications such as hypotony, tube occlusion, or endophthalmitis. Billing for the device uses L8612; professional and facility services are billed separately. Common payors include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|